Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder

Neuropsychobiology

Volumn 37, Issue 4, 1998, Pages 182-185

  Monteleone, Palmiero ^a,b   Catapano, Francesco ^a   Fabrazzo, Michele ^a   Tortorella, Alfonso ^a   Maj, Mario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Primo Policlinico Universitario   (Italy)

Author keywords

Cortisol; Immunity; Interleukins; Obsessive compulsive disorder; Tumor necrosis factor

Indexed keywords

HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPULSION; CONTROLLED STUDY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; OBSESSION; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYDROCORTISONE; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031803882     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026500     Document Type: Article

References (22)

1. Herbert TB, Cohen S: Depression and immunity: A meta-analytic overview. Psychol Bull 1993;113:472-486.
2. Monteleone P, Fabrazzo M, Tortorella A, Maj M: Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: Effects of clozapine treatment. Psychiatry Res 1997;71:11-17.
3. Karno M, Golding JM, Sorenson SB, Burnam A: The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988;45:1094-1099.
4. Catapano F, Monteleone P, Maj M, Kemali D: Dexamethasone suppression test in patients with primary obsessive-compulsive disorder and in healthy controls. Neuropsychobiology 1990;23:53-56.
5. Insel TR, Gillin JC, Moore A, Lowenstein R, Murphy DL, Mendelson W: Sleep in obsessivecompulsive disorder. Arch Gen Psychiatry 1982;39:1372-1377.
6. Khanna S, Gokul BN, Reddy PL, Khanna N, Channabasavanna SM: Humoral immune function in obsessive-compulsive disorder. Indian J Psychol Med 1990;13:31-37.
7. Khanna S, Ravi V, Shenoy PK, Chandramuki A, Channabasavanna SM: Cerebrospinal fluid viral antibodies in obsessive-compulsive disorder in an Indian population. Biol Psychiatry 1997;41:883-890.
8. Roy BF, Benkelfat C, Hill JL, Pierce PF, Dauphin MM, Kelly TM, Sunderland T, Weinberger DR, Breslin N: Serum antibody for somatostatin-14 and prodynorphin 209-240 in patients with obsessive-compulsive disorder, schizophrenia, Alzheimer's disease, multiple sclerosis, and advanced HIV infection. Biol Psychiatry 1994;35:335-344.
9. Barber Y, Toren P, Achiron A, Noy S, Wolmer L, Weizman R, Laor N: T cell subsets in obsessive-compulsive disorder. Neuropsychobiology 1996;34:63-66.
10. Maes M, Meltzer HY, Bosmans E: Psychoimmune investigation in obsessive-compulsive disorder: Assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations. Neuropsychobiology 1994;30:57-60.
11. Weizman R, Laor N, Barber Y. Hermesh H, Notti I, Djaldetti M, Bessler H: Cytokine production in obsessive-compulsive disorder. Biol Psychiatry 1996;40:908-912.
12. Basedowsky HO, Del Rey A: Immune-neuroendocrine interactions: Facts and hypotheses. Endocr Rev 1996;17:64-102.
13. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale (YBOCS): I. Development, use and reliability. Arch Gen Psychiatry 1989; 46:1006-1011.
14. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
15. Cottreaux JA, Bouvard M, Claustrat B, Juenet C: Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: A confirmatory report. Psychiatry Res 1984;13: 157-165.
16. Monteleone P, Catapano F, Del Buono G, Maj M: Circadian rhythms of melatonin, Cortisol and prolactin in patients with obsessive-compulsive disorder. Acta Psychiatr Scand 1994; 89:411-415.
17. O'Leary A: Stress, emotion, and human immune function. Psychol Bull 1990;108:363-392.
18. Zuckerman SH, Shellas J, Butler LD: Differential regulation of lipopolysaccharide-induced interleukin-1 and tumor necrosis factor synthesis: Effects of endogenous and exogenous glucocorticoids and the role of pituitary-adrenal axis. Eur J Immunol 1989;19:301-305.
19. La Via MF, Munno I, Lydiard RB, Workman EW, Hubbard JR, Michel Y, Paulling E: The influence of stress intrusion on immunodepres-sion in generalized anxiety disorder patients and controls. Psychosom Med 1996;58:138-142.
20. Lieberman AP, Pitha PM, Shin HS, Shin ML: Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or neurotropic viruses. Proc Natl Acad Sci USA 1989;399:608-612.
21. Kinouchi K, Brown G, Pasternak G, Donner DB: Identification and characterisation of receptors for tumor necrosis factor-alpha in the brain. Biochem Biophys Res Commun 1991; 181:1532-1538.
22. Krueger JM, Takahashi S, Kapas L, Bredow S, Roky R, Fang J, Floyd R, Renegar KB, GuhaThakurta N, Novitsky S, Obal F: Cytokines in sleep regulation. Adv Neuroimmunol 1995;5: 171-188.